Dow Chemical y DuPont han retrasado sus planes para culminar con la fusión de ambas empresas petroquímicas conforme se desarrolla su plan para facilitar la autorización de ésta operación por parte de autoridades de competencia. Las empresas anunciaron un ligero retraso, tras lograr un intercambio de activos con el fabricante de pesticidas FMC, por $1,600 millones de dólares.
Featured News
SEC and CFTC Release First-Ever Crypto Classification Framework
Mar 31, 2026 by
CPI
Meta Must Face Antitrust Lawsuit From Phhhoto, US Judge Rules
Mar 31, 2026 by
CPI
Federal Prosecutors Seeking Information on Possible Insider Trading on Polymarket
Mar 31, 2026 by
CPI
Senators Press SEC Chair Over Enforcement Chief’s Abrupt Exit Amid Crypto Case Questions
Mar 31, 2026 by
CPI
Biogen to Acquire Apellis in $5.6 Billion Deal to Expand Rare-Disease Portfolio
Mar 31, 2026 by
CPI
Antitrust Mix by CPI
Antitrust Chronicle® – Competitor Collaborations
Mar 26, 2026 by
CPI
Between Scylla and Charybdis – Navigating Transatlantic Antitrust Currents
Mar 26, 2026 by
Tilman Kuhn & Niklas Brüggemann
Cartel Enforcement Moves Into the Labor Market: Trends and Implications
Mar 26, 2026 by
Andreas Kafetzopoulos & Caroline Janssens
Rethinking Buy-Side Antitrust “Group Boycotts”
Mar 26, 2026 by
Craig Falls & Brendan McGuire
Positive Collaborations: The Tools Available to Competition Authorities to Encourage Beneficial Interactions Between Competitors
Mar 26, 2026 by
Rona Bar-Isaac & Thomas Withers